Free Trial

Alnylam Pharmaceuticals (ALNY) SEC Filings & 10K Form

$235.59
-2.24 (-0.94%)
(As of 07/22/2024 ET)

Recent Alnylam Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/12/2024
7:02 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:40 PM
Alnylam Pharmaceuticals (Subject)
Greenstreet Yvonne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2024
9:24 AM
Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G/A
05/31/2024
6:00 PM
Alnylam Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:34 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
7:21 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
7:11 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
3:37 PM
Alnylam Pharmaceuticals (Filer)
Form ARS
04/01/2024
3:31 PM
Alnylam Pharmaceuticals (Filer)
Form DEF 14A
03/04/2024
3:33 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
3:16 PM
Alnylam Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:17 PM
Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:18 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:18 PM
Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:18 PM
Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:00 PM
Alnylam Pharmaceuticals (Subject)
SHARP PHILLIP A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
7:35 AM
Alnylam Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/09/2024
7:40 AM
Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/05/2024
3:05 PM
Alnylam Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
11:18 AM
Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G/A
01/19/2024
3:31 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:00 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
7:22 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2023
6:30 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
6:30 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
4:00 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
5:04 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
5:04 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
5:05 PM
Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
5:05 PM
Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
7:18 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ALNY) was last updated on 7/23/2024 by MarketBeat.com Staff

From Our Partners